Searched for
ANTIVIRAL EFFICACY
Bangladeshi firm launches first generic of Pfizer drugBangladesh's directorate general of drug administration on Thursday granted emergency use authorisation for the oral antiviral drug to trea...- Bangladesh drug maker Beximco launches world's first generic of Pfizer's COVID antiviralPfizer's novel antiviral pill showed almost 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent data f...
- Pfizer pill becomes 1st US-authorized home COVID treatmentData from Pfizer's clinical trial showed its two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in pati...
- Pill 88% effective if given early, says PfizerFinal results of Paxlovid demonstrated reduction of hospitalisation or death by 89% among high-risk patients treated within three days of s...
- Pfizer says antiviral pill cut hospitalisation by 89%, neutralised Omicron in lab testsThe company said the 88% efficacy in patients treated within five days of symptom onset, was an increase from the 85% observed in the inter...
- COVID antiviral drug Molnupiravir efficacy against hospitalization or death drops to 30% compared to placebo groupThe analysis of latest data on efficacy is much less than the previous interim analysis announced by the company which was based on data fr...
- Sun Pharma says gearing up to launch COVID drug molnupiravirThe company said the Drugs Controller General of India (DCGI) is currently reviewing clinical data of molnupiravir for the treatment of COV...
- Pfizer rallies 8% on strong Q2 show, new Covid pillThe US multinational pharmaceutical and biotechnology firm further announced that its experimental antiviral pill to treat COVID-19 can cut...
- Pfizer starts large trial for anti-Covid pillIn the trial, PF-07321332, designed to block the activity of a key enzyme needed for the coronavirus to multiply, will be administered alon...
- New post-infection treatment for COVID-19 identifiedThese protease inhibitors are a class of antiviral drugs that prevent viral reproduction by selectively binding to viral enzymes and blocki...
- COVID-19: Ayurveda formulations to be tested by CCMB for checking anti-viral efficacyStandardised Ayurveda formulations provided by AVS in Kottakkal would be tested on the lab-grown coronavirus in the cell culture system, th...
- Repurposed anti-protozoal drug emetine effective against Covid: Indian scientistsScientists at National Centre for Veterinary Type Cultures have a unique collection of over 100 small molecule chemical inhibitors that are...
- No 'significant' benefit of favipiravir, umifenovir combination in Covid treatment: GlenmarkGlenmark had in May intimated the study to examine whether early administration of a combination of Favipiravir and Umifenovir enhances ant...
- Drug firms get DGCI nod for Covid drug favipiravir despite inconclusive studyOn Tuesday, Hyderabad-based Biophore India Pharmaceuticals said it has received approval from the Drug Controller General of India (DGCI) t...
- Glenmark Pharma cuts price of COVID-19 drug by 27% to Rs 75 per tabletIn a regulatory filing Glenmark announced a price reduction of 27 per cent for FabiFlu. The new maximum retail price (MRP) is Rs 75 per tab...
- Favirpiravir yet to find favour with ICMRHowever, the experts were not convinced and decided not to put it in the revised treatment protocol,” a person aware of the matter told ET ...
- Glenmark launches Favipiravir: Medics say 'no magic bullet' for COVID but will help amid rising cases"This drug was already being used in Japan for influenza. They have been using it in COVID-19 patients also. Even China was using it and Ru...
- FDA warns against co-administration of remdesivir with CQ or HCQ for COVID-19 patients"FDA is warning health care providers that co-administration of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not r...
- Russian drug to treat Covid to be delivered to hospitals in JuneAvifavir is Russia’s first COVID-19 drug and has shown high efficacy in treating patients with coronavirus during clinical trials. Avifavir...
- Two Mumbai companies step up work on COVID-19 drug helping in recoveryMumbai-based BDR Pharma, which makes anti-HIV and Hepatitis C medication, and LASA Supergenerics, an active pharmaceutical ingredient maker...
Load More
